🚨New Publication Alert for Clinicians! 🚨
​Do your IBD, RA, or Spondyloarthritis patients need skin cancer screening?
​Our Joint Bone Spine review proposes a pragmatic algorithm to identify IMID patients at increased risk. 👇
authors.elsevier.com/a/1luf0,TVsH...

🎓✨ Honoured to be appointed Associate Professor in Rheumatology at @chulille.bsky.social @ufr3s-ulille.bsky.social

🙏 Grateful to keep caring for patients, advancing research in chronic inflammatory diseases (esp. spondyloarthritis) & teaching future clinicians.

Thanks to all who supported me!

🎓 Congratulations to Astrid Goudot for her outstanding medical thesis defence in both 🇫🇷🇬🇧 on predictive factors of D2T PsA in patients initiating their 1st bDMARD. 👏👏

Many thanks to Laura Coates who shared her valuable expertise on this timely topic 🌍👏

🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social

🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social

Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.

Disagree Well. Speak truth. Challenge bias.

#Gaslighting #UnconsciousBias #EULAR2025
IH

📲 Inspiring work from Deniz Bayraktar at #EULAR2025!
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.

📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27

Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social

🧠✨GRAPPA Definitions

🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊

🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥

#EULAR2025
Posted by @jgletarouilly.bsky.social

🔬SPEED RCT in patients with PsA and poor prognostic factors

🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi

#EULAR2025
Posted by @jgletarouilly.bsky.social

🌟Thrilled and honoured to join @ard.eular.org as a guest Social Media Editor for #EULAR2025!🥳Thank you @alessiaalunno.bsky.social for the trust and support! Looking forward to sharing insights and highlights from this exciting congress. 🙌✨

Good morning Barcelona! We are fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors.

👉🏻Follow along for live updates!

Make the most of #EULAR2025 with the official Congress App!

🗺️ Navigate the 4-day event with ease, find session info, symposia, exhibition highlights, and venue services.
🗓️ Build your personal schedule
📱Download the EULAR 2025 Congress App and elevate your experience!

#rheumatology

📢 Welcome to the ARD BlueSky
Channel!

👉🏻 Follow along for the latest updates on published articles and more!

🎤 Stay tuned also for live coverage from #EULAR2025 Congress taking place in Barcelona on 11-14 June 2025.

📖 Browse the journal at www.sciencedirect.com/journal/anna...

🎙️ New EMEUNET #Podcast!
✨ RheumaVision 2025 Explained 🎥

How was #RheumaVision created? What's coming at #EULAR2025? 🚀

Join Renske, @jgletarouilly.bsky.social @TueKragstrup & me for a behind-the-scenes look!

🎧 Listen here 👉 open.spotify.com/episode/1TFg7j…

Look forward to chairing with you this exciting final of #RheumaVision! Our 6 finalists will present their topics to a prestigious jury: Denis Poddubnyy, Jette Primdahl, Caroline Ospelt and Simon Stones.
Audience vote will be essential so join us! 🎉

We’re proud to reveal the #RheumaVision 2025 FINALISTS! 🎉
Brilliant early career rheumatologists sharing science through storytelling 🎥✨

Catch them at the Grand Finale during #EULAR2025 in Barcelona 🇪🇸

@jgletarouilly.bsky.social @eular.org @emeunet